HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe

被引:63
作者
Ballerini, C
Guerini, FR
Rombolà, G
Rosati, E
Massacesi, L
Ferrante, P
Caputo, D
Talamanca, LF
Naldi, P
Liguori, M
Alizadeh, M
Momigliano-Richiardi, P
D'Alfonso, S
机构
[1] Univ Piemonte Orientale, IRCAD, Dipartimento Sci Med & Interdisciplinary Res Ctr, I-28100 Novara, Italy
[2] Univ Florence, Dipartimento Sci Neurol & Psichiat, Florence, Italy
[3] IRCCS, Fondaz Don C Gnocchi ONLUS, Biol Lab, Milan, Italy
[4] Immunogenet AO Careggi, Florence, Italy
[5] Univ Milan, Dipartimento Sci Biomed & Tecnol, Cattedra Virol, Milan, Italy
[6] IRCCS, Fondaz Don C Gnocchi ONLUS, Unita Sclerosi Multipla, Milan, Italy
[7] Univ Roma La Sapienza, Neurol Osped S Andrea, Rome, Italy
[8] Osped Maggiore La Carita, Clin Neurol, Novara, Italy
[9] Univ Bari, Dipartimento Neurol & Sci Psichiat, Bari, Italy
[10] UPRES, EA 1257, IFR 97, Rennes, France
[11] Etablissement Francais Sang Bretagne, Fac Med, Rennes, France
关键词
multiple sclerosis; HLA;
D O I
10.1016/j.jneuroim.2004.01.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The association with HLA-DRB1 alleles was tested in 609 Continental Italian MS patients and 836 controls. The phenotype frequency of DRB1*15 in the patients was significantly, higher (0.316 vs. 0.112;p(c)<10(-6); Odds Ratio (OR) -3.64) with no dose effect. DRB1*10 was also significantly increased (OR= 2.19; p(c)=0.047) and DRB1*07 decreased (OR= 0.60; p(c)= 1.3 x 10(-3)) independently of DR15 and of each other. We did not detect an influence of the DR phenotype on disease course, age at onset/diagnosis, gender or familiarity. No association with Class I was detected in a random subset of patients and controls. A comparison of the HLA association data in Northern and Southern European populations shows a parallel between disease prevalence and DR15 frequency. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:178 / 185
页数:8
相关论文
共 45 条
[1]   Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients [J].
Alizadeh, M ;
Babron, MC ;
Birebent, B ;
Matsuda, F ;
Quelvennec, E ;
Liblau, R ;
Cournu-Rebeix, I ;
Momigliano-Richiardi, P ;
Sequeiros, J ;
Yaouanq, J ;
Genin, E ;
Vasilescu, A ;
Bougerie, H ;
Trojano, M ;
Silva, BM ;
Maciel, P ;
Clerget-Darpoux, F ;
Clanet, M ;
Edan, G ;
Fontaine, B ;
Semana, G .
ANNALS OF NEUROLOGY, 2003, 54 (01) :119-122
[2]   Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster [J].
Allcock, RJN ;
de la Concha, EG ;
Fernandez-Arquero, M ;
Vigil, P ;
Conejero, L ;
Arroyo, R ;
Price, P .
HUMAN IMMUNOLOGY, 1999, 60 (12) :1266-1273
[3]   HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course [J].
Barcellos, LF ;
Oksenberg, JR ;
Begovich, AB ;
Martin, ER ;
Schmidt, S ;
Vittinghoff, E ;
Goodin, DS ;
Pelletier, D ;
Lincoln, RR ;
Bucher, P ;
Swerdlin, A ;
Perick-Vance, MA ;
Haines, JL ;
Hauser, SL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (03) :710-716
[4]   HLA class I and class II allele and haplotype diversity in Martinicans [J].
Bera, O ;
Cesaire, R ;
Quelvennec, E ;
Quillivic, F ;
de Chavigny, V ;
Ribal, C ;
Semana, G .
TISSUE ANTIGENS, 2001, 57 (03) :200-207
[5]  
Casetta I, 1991, Riv Neurol, V61, P12
[6]   Further characterization of MHC haplotypes demonstrates conservation telomeric of HLA-A: update of the 4AOH and 10IHW cell panels [J].
Cattley, SK ;
Williamson, JF ;
Tay, GK ;
Martinez, OP ;
Gaudieri, S ;
Dawkins, RL .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 2000, 27 (5-6) :397-426
[7]   ANALYSIS OF HLA-CLASS-II DQA1, DQB1, DRB1 AND DPB1 IN ITALIAN MULTIPLE-SCLEROSIS PATIENTS [J].
CIUSANI, E ;
ALLEN, M ;
SANDBERGWOLLHEIM, M ;
EOLI, M ;
SALMAGGI, A ;
MILANESE, C ;
NESPOLO, A ;
GYLLENSTEN, U .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1995, 22 (02) :171-178
[8]   Genetic analysis of multiple sclerosis. [J].
Compston A. ;
Sawcer S. .
Current Neurology and Neuroscience Reports, 2002, 2 (3) :259-266
[9]   HLA associations with multiple sclerosis in the Canary Islands [J].
Coraddu, F ;
Reyes-Yanez, MP ;
Parra, A ;
Gray, J ;
Smith, SI ;
Taylor, CJ ;
Compston, DAS .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 87 (1-2) :130-135
[10]   Evidence for additional genetic risk indicators of relapse-onset MS within the HLA region [J].
de Jong, BA ;
Huizinga, TWJ ;
Zanelli, E ;
Giphart, MJ ;
Bollen, ELEM ;
Uitdehaag, BMJ ;
Polman, CH ;
Westendorp, RGJ .
NEUROLOGY, 2002, 59 (04) :549-555